Tsai H, Hsu P, Pan L, Hung C, Yang D, Hung K
BMC Cardiovasc Disord. 2023; 23(1):375.
PMID: 37507664
PMC: 10375620.
DOI: 10.1186/s12872-023-03406-5.
Ismail L, Materwala H, Al Kaabi J
Comput Struct Biotechnol J. 2021; 19:1759-1785.
PMID: 33897980
PMC: 8050730.
DOI: 10.1016/j.csbj.2021.03.003.
Roberts R, Chang C, Hadley T
JACC Basic Transl Sci. 2021; 6(3):287-304.
PMID: 33778213
PMC: 7987546.
DOI: 10.1016/j.jacbts.2020.09.004.
Ching S, Chia Y, Lentjes M, Luben R, Wareham N, Khaw K
BMC Public Health. 2019; 19(1):501.
PMID: 31053065
PMC: 6500069.
DOI: 10.1186/s12889-019-6818-x.
Bucholz E, Krumholz H
Circ Cardiovasc Qual Outcomes. 2015; 8(2 Suppl 1):S1-3.
PMID: 25714827
PMC: 4415379.
DOI: 10.1161/CIRCOUTCOMES.115.001756.
Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial.
Stamler J, Neaton J, Cohen J, Cutler J, Eberly L, Grandits G
J Am Heart Assoc. 2013; 1(5):e003640.
PMID: 23316301
PMC: 3541632.
DOI: 10.1161/JAHA.112.003640.
Risk factor modification and projections of absolute breast cancer risk.
Petracci E, Decarli A, Schairer C, Pfeiffer R, Pee D, Masala G
J Natl Cancer Inst. 2011; 103(13):1037-48.
PMID: 21705679
PMC: 3131219.
DOI: 10.1093/jnci/djr172.
Inclusion of women in clinical trials.
Berlin J, Ellenberg S
BMC Med. 2009; 7:56.
PMID: 19818115
PMC: 2763864.
DOI: 10.1186/1741-7015-7-56.
[Standard-ECG].
Gonska B
Herzschrittmacherther Elektrophysiol. 2008; 19(3):89-97.
PMID: 18956156
DOI: 10.1007/s00399-008-0020-7.
Screening for coronary heart disease: cardiology through the oncology looking glass.
Miller D, Shaw L
J Nucl Cardiol. 2005; 12(2):158-65.
PMID: 15812369
DOI: 10.1016/j.nuclcard.2004.12.292.
High-risk studies are influenced by indirect range restriction.
Miller T
J Behav Med. 1994; 17(6):567-88.
PMID: 7739031
DOI: 10.1007/BF01857598.
Trends in mortality and possible influences on the decline in mortality from cardiovascular disease.
Hickey N, Mulcahy R, Graham I, Daly L
Ir J Med Sci. 1980; 149(10):404-7.
PMID: 7228585
DOI: 10.1007/BF02939179.
Some considerations for the planning of total-community prevention trials--when is sample size adequate?.
Gillum R, Williams P, Sondik E
J Community Health. 1980; 5(4):270-8.
PMID: 6995504
DOI: 10.1007/BF01324196.
Stressful life events, Type A behavior, and the prediction of cardiovascular and total mortality over six years. MRFIT Group.
Hollis J, Connett J, Stevens V, Greenlick M
J Behav Med. 1990; 13(3):263-80.
PMID: 2213869
DOI: 10.1007/BF00846834.
[Principles and problems of evaluation of results in health education].
Schar M
Soz Praventivmed. 1978; 23(2):101-3.
PMID: 685481
DOI: 10.1007/BF02075233.
